Standard versus Hydrophilic Catheterization in the Adjuvant Treatment of Patients with Superficial Bladder Cancer
Authors:
- Luca CindoloLCLuca Cindolo
- Emiliano A. PalmieriEPEmiliano A. Palmieri
- Riccardo AutorinoRARiccardo Autorino
- Luigi SalzanoLSLuigi Salzano
- Vincenzo AltieriVAVincenzo Altieri
- 1 July 2004
- journal article
- clinical trial
- Published by S. Karger AG in Urologia Internationalis
- Vol. 73 (1) , 19-22
Abstract
Introduction: The aim of the present study is to compare a hydrophilic catheter to the standard polyvinyl chloride catheter with regard to bacteriological safety and overall comfort in patients undergoing intravesical immuno- or chemotherapy for bladder cancer. Materials and Methods: One hundred patients (80 males, 20 females; median age 65.8 years, range 48–79 years) eligible for intravesical prophylaxis of superficial bladder cancer recurrences were randomized to receive intravesical therapy using a standard catheter (group A, n = 50) or a hydrophilic catheter (group B, n = 50). Urinalysis and urine culture were performed 2 days after catheterization. Comfort during catheterization was assessed by a 5-point visual analogue scale at the end of the first four instillations. Results: Urinary tract infection (UTI) was detected in 7.4% of catheterizations in group A, whereas it occurred in 3.5% of catheterizations in group B (p < 0.01). Escherichia coli was the most frequent pathogen regardless of the device used. At the end of each of the first four instillations, the mean score for discomfort was significantly higher in group A than in group B (p < 0.001), although catheterization was progressively better tolerated regardless of the device used (both p < 0.005). None of the patients were found to be suffering from orchitis, epididymitis or gross haematuria. Conclusion: Hydrophilic catheters may be used safely and are well tolerated by patients undergoing intravesical immuno- or chemotherapy. The hydrophilic catheter was associated with a significantly lower occurrence of UTI and higher acceptability compared to the standard device. These data should be considered with regard to patient compliance with intravesical therapy.Keywords
This publication has 10 references indexed in Scilit:
- Guidelines on Bladder CancerEuropean Urology, 2002
- Randomized Trial of 10 mL and 20 mL of 2% Intraurethral Lidocaine Gel and Placebo in Men Undergoing Flexible CystoscopyJournal of Endourology, 2001
- Hydrophilic versus Non-coated Catheters for Intermittent CatheterizationScandinavian Journal of Urology and Nephrology, 2001
- TrueSpinal Cord, 2000
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- Urethral epithelial cells on the surface on hydrophilic catheters after intermittent catheterization: cross-over study with two cathetersSpinal Cord, 1999
- Clean Intermittent Catheterization in Boys Using the Lofric CatheterJournal of Urology, 1996
- The Effect of Lubricants on Viability of Bacillus Calmette-Guerin for Intravesical Immunotherapy Against Bladder CarcinomaJournal of Urology, 1996
- Clean Intermittent Catheterization in Spinal Cord Injury Patients: Long-Term Followup of a Hydrophilic Low Friction TechniqueJournal of Urology, 1995
- Patient Satisfaction and the Lofric Catheter for Clean Intermittent CatheterizationJournal of Urology, 1995